Oral Solid Dosage Contract Manufacturing Market Size, Share, Growth, Analysis & Forecast 2032 | Credence Research
The latest market report published by Credence Research, Inc. The global demand for the OSD Contract Manufacturing Market was valued at USD 26,956.76 Million in 2023 is expected to reach USD 48,167.19 Million in 2032 growing at a CAGR of 6.40% between 2024 and 2032.
In the pharmaceutical industry, the demand for oral solid dosage (OSD) forms remains steadfast, owing to their convenience, stability, and ease of administration. As the market for OSD drugs continues to expand, pharmaceutical companies are increasingly turning to contract manufacturing organizations (CMOs) to fulfill their production needs. This trend has given rise to a thriving Oral Solid Dosage Contract Manufacturing Market, which is witnessing robust growth and evolution.
The OSD contract manufacturing market encompasses a wide range of services, including formulation development, manufacturing, packaging, and quality control. One of the primary drivers of this market's growth is the increasing complexity of drug formulations and the need for specialized expertise in manufacturing techniques and technologies. Pharmaceutical companies often lack the infrastructure and resources to produce OSD drugs in-house, making outsourcing an attractive option.
Browse the Full Report: https://www.credenceresearch.com/report/oral-solid-dosage-contract-manufacturing-market














